Clinical Trial Update: Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is recruiting to compare Cofrogliptin added to metformin and dapagliflozin versus daily Linagliptin in patients with Type 2 diabetes me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Cofrogliptin (Cofrogliptin)
• Dapagliflozin (dapagliflozin)
• Linagliptin (linagliptin)
• metformin (metformin)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: T2DM | Phase 4 | Status: RECRUITING